Drug Profile
Research programme: anti-fungals - Agrivir
Latest Information Update: 22 Sep 2006
Price :
$50
*
At a glance
- Originator Agrivir
- Developer Agrivir; BioAgri; Medivir AB
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 31 Dec 2005 Discontinued - Preclinical for Mycoses in Sweden (unspecified route)
- 23 Oct 2001 New profile
- 23 Oct 2001 Preclinical development for Mycoses in Sweden (Unknown route)